Wave Life Sciences Stock Analysis
| WVE Stock | USD 7.87 0.47 5.64% |
Wave Life Sciences is undervalued with Real Value of 10.7 and Hype Value of 7.81. The main objective of Wave Life stock analysis is to determine its intrinsic value, which is an estimate of what Wave Life Sciences is worth, separate from its market price. There are two main types of Wave Life's stock analysis: fundamental analysis and technical analysis.
The Wave Life stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Wave Life's ongoing operational relationships across important fundamental and technical indicators.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. Wave Stock Analysis Notes
About 16.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.75. Wave Life Sciences had not issued any dividends in recent years. Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company was incorporated in 2012 and is based in Singapore. Wave Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 235 people. For more information please call MBA MD at 65 6236 3388 or visit https://wavelifesciences.com.Wave Life Sciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Wave Life's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Wave Life Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Wave Life Sciences had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 108.3 M. Reported Net Loss for the year was (97.01 M) with loss before taxes, overhead, and interest of (61.92 M). | |
| Wave Life Sciences has about 148.16 M in cash with (151.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. | |
| Wave Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Over 84.0% of the company outstanding shares are owned by institutional investors |
Wave Life Sciences Upcoming and Recent Events
| 27th of March 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Wave Market Capitalization
The company currently falls under 'Mid-Cap' category with a total capitalization of 1.3 B.Wave Profitablity
The company has Net Profit Margin of (1.07) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (5.43) %, which entails that for every $100 of revenue, it lost $5.43.Technical Drivers
As of the 22nd of July, Wave Life maintains the Mean Deviation of 2.83, downside deviation of 4.96, and Market Risk Adjusted Performance of 1.47. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Wave Life Sciences, as well as the relationship between them. Please check out Wave Life Sciences coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Wave Life Sciences is priced fairly, providing market reflects its latest price of 7.87 per share. Given that Wave Life Sciences has jensen alpha of 0.3279, we strongly advise you to confirm Wave Life Sciences's prevalent market performance to make sure the company can sustain itself at a future point.Wave Life Sciences Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Wave Life for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Wave Life Sciences short-term fluctuations and highlight longer-term trends or cycles.
Wave Life Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Wave Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Wave Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Wave Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chandra Vargeese over three months ago Acquisition by Chandra Vargeese of 60000 shares of Wave Life at 2.83 subject to Rule 16b-3 | ||
Chandra Vargeese over three months ago Disposition of 46000 shares by Chandra Vargeese of Wave Life at 2.48 subject to Rule 16b-3 | ||
Chandra Vargeese over a year ago Acquisition by Chandra Vargeese of 50000 shares of Wave Life at 10.48 subject to Rule 16b-3 | ||
Adrian Rawcliffe over a year ago Acquisition by Adrian Rawcliffe of 45000 shares of Wave Life at 4.58 subject to Rule 16b-3 | ||
Chandra Vargeese over a year ago Acquisition by Chandra Vargeese of 361700 shares of Wave Life subject to Rule 16b-3 | ||
Ken Takanashi over a year ago Acquisition by Ken Takanashi of 45000 shares of Wave Life subject to Rule 16b-3 | ||
Chandra Vargeese over a year ago Sale by Chandra Vargeese of 10249 shares of Wave Life |
Wave Life Outstanding Bonds
Wave Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Wave Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Wave bonds can be classified according to their maturity, which is the date when Wave Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Wave Life Predictive Daily Indicators
Wave Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Wave Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 196729.0 | |||
| Daily Balance Of Power | (0.52) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 8.27 | |||
| Day Typical Price | 8.13 | |||
| Price Action Indicator | (0.63) | |||
| Period Momentum Indicator | (0.47) |
Wave Life Forecast Models
Wave Life's time-series forecasting models are one of many Wave Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Wave Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Wave Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Wave Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Wave shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Wave Life. By using and applying Wave Stock analysis, traders can create a robust methodology for identifying Wave entry and exit points for their positions.
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company was incorporated in 2012 and is based in Singapore. Wave Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 235 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Wave Life to your portfolios without increasing risk or reducing expected return.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Complementary Tools for Wave Stock analysis
When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world |